{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:26:57Z","timestamp":1787286417966,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The integrity of the intestinal mucosal barrier is critical in the pathogenesis of Inflammatory Bowel Disease (IBD). While Astragaloside IV (ASIV) possesses potent anti-inflammatory properties, its specific effects on intestinal epithelial barrier function and the underlying mechanisms involving the Myosin Light Chain Kinase (MLCK) and Myeloid Differentiation Primary Response 88\/TNF Receptor-Associated Factor 6 (MyD88\/TRAF6) pathways in colitis remain elusive. This study aimed to investigate the protective effects of ASIV on tight junction (TJ) proteins and inflammatory signaling in dextran sulfate sodium (DSS)-induced colitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A chronic colitis model was established in wild-type C57BL\/6 mice using four cycles of DSS administration. ASIV (30\u00a0mg\/kg\/day) was administered orally starting from day 14. Disease activity index (DAI), colon length, and histopathological changes were assessed. Intestinal barrier function was evaluated by measuring bacterial translocation, colonic permeability to fluorescein isothiocyanate (FITC)-dextran, and serum lipopolysaccharide (LPS) levels. The expression of TJ proteins (ZO-1, Occludin, JAM-A, Claudin-2) and signaling molecules (MLCK, phosphorylated myosin light chain (p-MLC), MyD88, TRAF6) was determined by Western blot and quantitative real-time PCR (qRT-PCR). Representative immunofluorescence localization of Claudin-2 and ZO-1 in colonic tissues was included as supplementary qualitative evidence of tight junction remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ASIV treatment significantly attenuated DSS-induced weight loss, colon shortening, and histopathological damage (p &amp;lt; 0.05). Furthermore, ASIV markedly reduced colonic permeability, serum LPS levels, and bacterial translocation to mesenteric lymph nodes (p &amp;lt; 0.01). At the molecular level, ASIV reversed the DSS-induced downregulation of sealing TJs (ZO-1, Occludin, JAM-A) and suppressed the upregulation of the pore-forming protein Claudin-2 (p &amp;lt; 0.05). These protective effects were accompanied by significant inhibition of TNF-\u03b1 mRNA expression, reduced MLCK protein expression, decreased MLC phosphorylation, and suppression of MyD88\/TRAF6 signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ASIV effectively restores intestinal epithelial barrier integrity in experimental colitis. These protective effects are associated with rebalancing of TJ protein expression and localization and may be partially linked to attenuation of the TNF-\u03b1\/MLCK\/p-MLC and LPS\/MyD88\/TRAF6 signaling axes. These findings support ASIV as a promising barrier-protective candidate for mucosal homeostasis in IBD, while future cellular and pathway-intervention studies are needed to establish direct causality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1778530","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:22:36Z","timestamp":1787286156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Astragaloside IV ameliorates DSS-induced intestinal epithelial barrier dysfunction associated with modulation of tight junction proteins and MLCK\/p-MLC and MyD88\/TRAF6 signaling pathways"],"prefix":"10.3389","volume":"17","author":[{"given":"Mingyue","family":"Yang","sequence":"first","affiliation":[{"name":"Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei Provincial Hospital of Chinese Medicine","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Duan","sequence":"additional","affiliation":[{"name":"Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Huo","sequence":"additional","affiliation":[{"name":"Gastrointestinal Disease Diagnosis and Treatment Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei Provincial Hospital of Chinese Medicine","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat. Immunology"},{"key":"B2","volume-title":"AVMA Guidelines for the Euthanasia of Animals: 2020 Edition","year":"2020"},{"key":"B3","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-022-02208-x","article-title":"RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4\/MyD88\/NF-\u03baB signaling and ameliorates murine colitis","volume":"22","author":"Duan","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000504701","article-title":"Gender differences in inflammatory bowel disease","volume":"101","author":"Greuter","year":"2020","journal-title":"Digestion"},{"key":"B6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.13414","article-title":"Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease","volume":"1401","author":"Guo","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"153179","DOI":"10.1016\/j.phymed.2020.153179","article-title":"Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK\/pMLC2 pathway","volume":"68","author":"Huang","year":"2020","journal-title":"Phytomedicine International Journal Phytotherapy Phytopharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.05.013","article-title":"Inflammatory bowel disease as a model for translating the microbiome","volume":"40","author":"Huttenhower","year":"2014","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104835","DOI":"10.1016\/j.phrs.2020.104835","article-title":"Cytokines in inflammatory bowel diseases - update 2020","volume":"158","author":"Leppkes","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/fcp.12232","article-title":"Research review on the pharmacological effects of astragaloside IV","volume":"31","author":"Li","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e19811","DOI":"10.1371\/journal.pone.0019811","article-title":"Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e977176","DOI":"10.4161\/21688370.2014.977176","article-title":"Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation","volume":"3","author":"Luettig","year":"2015","journal-title":"Tissue Barriers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend Your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell. Mol. Gastroenterology Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41575-020-00399-w","article-title":"The intestinal barrier, an arbitrator turned provocateur in IBD","volume":"18","author":"Mehandru","year":"2021","journal-title":"Nat. Reviews Gastroenterology & Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/BF01303184","article-title":"Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin","volume":"38","author":"Murthy","year":"1993","journal-title":"Dig. Dis. Sci."},{"key":"B16","first-page":"963","volume-title":"Guide for the Care and Use of Laboratory Animals","year":"2010"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2217877121","DOI":"10.1073\/pnas.2217877121","article-title":"Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis","volume":"121","author":"Oami","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/biomedicines13020406","article-title":"Immunohistochemistry analysis in inflammatory bowel disease-should we bring to light Interleukin-10?","volume":"13","author":"Pavel","year":"2025","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.3390\/molecules28176293","article-title":"Natural products: a dependable source of therapeutic alternatives for inflammatory bowel disease through regulation of tight junctions","volume":"28","author":"Peng","year":"2023","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1172\/JCI138697","article-title":"Inactivation of paracellular cation-selective claudin-2 channels attenuates immune-mediated experimental colitis in mice","volume":"130","author":"Raju","year":"2020","journal-title":"J. Clinical Investigation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","article-title":"TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis","volume":"145","author":"Su","year":"2013","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1096\/fj.201901638RR","article-title":"Pharmacological activation of ER\u03b2 by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases","volume":"34","author":"Tao","year":"2020","journal-title":"FASEB J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"740565","DOI":"10.3389\/fimmu.2021.740565","article-title":"Astragaloside IV alleviates the experimental DSS-induced colitis by remodeling macrophage polarization through STAT signaling","volume":"12","author":"Tian","year":"2021","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/molecules29010241","article-title":"Astragalus polysaccharide alleviates ulcerative colitis by regulating the balance of mTh17\/mTreg cells through TIGIT\/CD155 signaling","volume":"29","author":"Wan","year":"2024","journal-title":"Molecules"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.2012.06528.x","article-title":"Dynamic properties of the tight junction barrier","volume":"1257","author":"Weber","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/nu10060685","article-title":"Small intestinal permeability and gut-transit time determined with low and high molecular weight fluorescein isothiocyanate-dextrans in C3H mice","volume":"10","author":"Woting","year":"2018","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3892\/etm.2019.7907","article-title":"Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo","volume":"18","author":"Wu","year":"2019","journal-title":"Exp. Therapeutic Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trsl.2016.04.009","article-title":"Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets","volume":"176","author":"Yadav","year":"2016","journal-title":"Transl. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.12998\/wjcc.v10.i28.10004","article-title":"Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation","volume":"10","author":"Yang","year":"2022","journal-title":"World Journal Clinical Cases"},{"key":"B32","doi-asserted-by":"publisher","first-page":"274314","DOI":"10.1155\/2015\/274314","article-title":"Astragaloside IV inhibits NF- \u03ba B activation and inflammatory gene expression in LPS-treated mice","volume":"2015","author":"Zhang","year":"2015","journal-title":"Mediat. Inflammation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.intimp.2016.10.021","article-title":"Zanthoxylum bungeanum pericarp extract prevents dextran sulfate sodium-induced experimental colitis in mice via the regulation of TLR4 and TLR4-related signaling pathways","volume":"41","author":"Zhang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","article-title":"Astragaloside IV derived from astragalus membranaceus: a research review on the pharmacological effects","volume":"87","author":"Zhang","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-024-05168-w","article-title":"Blockade of PI3K\/AKT signaling pathway by astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1778530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:22:37Z","timestamp":1787286157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1778530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":35,"alternative-id":["10.3389\/fphar.2026.1778530"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1778530","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1778530"}}